Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial
No effective treatments for coronavirus disease 2019 (COVID-19) exist. We aimed to determine whether early treatment with hydroxychloroquine (HCQ) would be efficacious for outpatients with COVID-19.
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | artículo biblioteca |
Language: | English |
Published: |
Oxford University Press
2021-12-01
|
Subjects: | COVID-19, SARS-CoV-2, Hydroxychloroquine, Randomized controlled trial, Therapy, |
Online Access: | http://hdl.handle.net/10261/259501 https://api.elsevier.com/content/abstract/scopus_id/85122546667 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|